Sign Up to like & get
recommendations!
0
Published in 2020 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.02461-20
Abstract: We evaluated β-lactam-resistant baseline Enterobacterales species and Pseudomonas aeruginosa lower respiratory tract isolates collected during the ASPECT-NP phase 3 clinical trial evaluating the safety and efficacy of ceftolozane-tazobactam compared with meropenem for the treatment of…
read more here.
Keywords:
ceftolozane tazobactam;
baseline enterobacterales;
trial;
aeruginosa isolates ... See more keywords